|
ZNF567 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.27100000524294E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.61200000001494E-06 |
| Normal-vs-Stage2 |
1.5466899999983E-05 |
| Normal-vs-Stage3 |
8.1555000530642E-09 |
| Normal-vs-Stage4 |
1.04109999510271E-08 |
| Stage1-vs-Stage2 |
2.170000E-01 |
| Stage1-vs-Stage3 |
1.849580E-02 |
| Stage1-vs-Stage4 |
2.679100E-03 |
| Stage2-vs-Stage3 |
6.239200E-01 |
| Stage2-vs-Stage4 |
2.459200E-01 |
| Stage3-vs-Stage4 |
4.363200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.2256999960012E-08 |
| Normal-vs-AfricanAmerican |
1.155760E-03 |
| Normal-vs-Asian |
2.119400E-03 |
| Caucasian-vs-AfricanAmerican |
8.129000E-01 |
| Caucasian-vs-Asian |
3.076600E-01 |
| AfricanAmerican-vs-Asian |
4.232200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.8670000030171E-08 |
| Normal-vs-Female |
9.65890000204084E-08 |
| Male-vs-Female |
5.333600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.71847000000058E-05 |
| Normal-vs-Age(41-60Yrs) |
1.46370000009277E-07 |
| Normal-vs-Age(61-80Yrs) |
1.34719999600463E-08 |
| Normal-vs-Age(81-100Yrs) |
6.222800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.772790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.746060E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.426200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.216800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.286400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.760600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.977670E-03 |
| Classical-VS-Follicular |
4.360600E-03 |
| Classical-VS-Other |
8.785000E-01 |
| Classical-VS-Normal |
4.51109999999311E-06 |
| Tall-VS-Follicular |
5.594000E-01 |
| Tall-VS-Other |
3.763800E-01 |
| Tall-VS-Normal |
7.49199999816597E-08 |
| Follicular-VS-Other |
4.633000E-01 |
| Follicular-VS-Normal |
9.3413000001874E-08 |
| Other-VS-Normal |
8.746300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.20459999974898E-07 |
| Normal-vs-N1 |
4.93580000004989E-06 |
| N0-vs-N1 |
8.160200E-01 |
|
|
